An 18-week experimental study examining the effects of topiramate on tobacco smoking and alcohol use found no differences ...

VESALIUS-CV was big in 2025, but studies looking at triglycerides, CRISPR, and oral GLP-1s also made the highlight reel.

"That will to live, that effort," the teenager's coach said. "That's what's missing in kids these days sometimes. She had it.

Heavy fentanyl users may derive greater benefit from a higher dose of extended-release buprenorphine maintenance therapy, a randomized controlled trial suggests.

Former senator Ben Sasse announced his stage 4 pancreatic cancer diagnosis in 2025, calling it "a death sentence" while ...

In the last year or so, health influencers -- and a lot of women on social media -- have talked up testosterone therapy as a kind of perimenopausal panacea. They promise boundless energy, crisper ...

A. O. Smith Corporation is rated a Buy with risk/reward attractive as growth and margins are set to accelerate from FY26.

A groundbreaking treatment for Parkinson’s disease and essential tremor is now available in Kentucky and the Norton ...

An analysis of CIRDC, dissecting the polymicrobial nature of the syndrome and outlining standards for diagnostic testing.

Millions of people in the U.S. and around the world are living with hepatitis C virus (HCV). But over the past decade, direct-acting antivirals (DAA) have proven effective against HCV, curing more ...

Doctors Ben and Sean Behnam built an alternative to one-size-fits-all solutions with their new company, Happy Head.

As millions of Americans hit the road or take to the skies for the holidays, another seasonal traveler is picking up speed: influenza.